Success Metrics

Clinical Success Rate
100.0%

Based on 9 completed trials

Completion Rate
100%(9/9)
Active Trials
1(8%)
Results Posted
67%(6 trials)

Phase Distribution

Ph not_applicable
12
92%
Ph phase_3
1
8%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution13 total trials
Phase 3Large-scale testing
1(7.7%)
N/ANon-phased studies
12(92.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

9 of 9 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

13

all time

Status Distribution
Active(2)
Completed(9)
Other(2)

Detailed Status

Completed9
unknown2
Not yet recruiting1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
13
Active
1
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 31 (7.7%)
N/A12 (92.3%)

Trials by Status

completed969%
not_yet_recruiting18%
unknown215%
recruiting18%

Recent Activity

Clinical Trials (13)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
13